Drug for treating psoriasis

Abstract

The invention belongs to the technical field of Chinese patent medicines, specifically relates to a drug for treating psoriasis, and is mainly used for solving the defects that the existing drug for treating the psoriasis causes atrophoderma and angiotelectasis after being taken for a long time, symptoms are easy to relapse again and the pathogenetic condition relapses after drug withdrawal, and curative effect is bad. The drug for treating psoriasis adopts the following medicines in parts by weight as raw material medicines: 4-5 parts of radix astragali, 1-2 parts of herba schizonepetae, 1-2 parts of ligusticum wallichii, 1-2 parts of Chinese angelica, 2-4 parts of dried rehamnnia roots, 2-4 parts of red peony roots, 2-4 parts of tribulus terrestris, 2-4 parts of polygonum multiflorum, 2-4 parts of cornu bubali, 2-4 parts of galium elegans, 2-4 parts of garter snakes and 1-3 parts of divaricate saposhnikovia roots. The drug for treating psoriasis disclosed by the invention has the advantages of being remarkable in medical effect and capable of treating both symptoms and root causes.

Description

technical field

[0001] The invention belongs to the technical field of Chinese patent medicines, in particular to a medicine for treating psoriasis. Background technique

[0002] Psoriasis is a common chronic inflammatory skin disease. It is a disease of polygenic inheritance, which can be induced by various triggering factors, such as trauma, infection, drugs, etc., in susceptible individuals. The typical cutaneous appearance is well-demarcated erythematous plaques with silvery white scales. In mild cases, it may manifest as several silver coin-sized plaques on the elbow and knees, and in severe cases, the skin of the whole body may also be involved. Its pathophysiological mechanism is mainly the abnormality of epidermal hyperplasia and differentiation and the activation of immune system. Because psoriasis is a chronic disease and affects a wide range of people, it has a great impact on the lives of patients. Itching, scaling, and visible plaques are the main problems t...